Autolus Therapeutics plc Quarterly Interest Expense in USD from Q1 2022 to Q4 2024

Taxonomy & unit
us-gaap: USD
Description
Amount of the cost of borrowed funds accounted for as interest expense.
Summary
Autolus Therapeutics plc quarterly/annual Interest Expense history and growth rate from Q1 2022 to Q4 2024.
  • Autolus Therapeutics plc Interest Expense for the quarter ending December 31, 2024 was -$30.8M, a 202% decline year-over-year.
  • Autolus Therapeutics plc Interest Expense for the twelve months ending December 31, 2024 was $9.29M, a 79.4% decline year-over-year.
  • Autolus Therapeutics plc annual Interest Expense for 2024 was $9.29M, a 79.4% decline from 2023.
  • Autolus Therapeutics plc annual Interest Expense for 2023 was $45.1M, a 406% increase from 2022.
  • Autolus Therapeutics plc annual Interest Expense for 2022 was $8.91M, a 706% increase from 2021.
Interest Expense, Trailing 12 Months (USD)
Interest Expense, Quarterly (USD)
Interest Expense, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q4 2024 $9.29M -$30.8M -$61M -202% Oct 1, 2024 Dec 31, 2024 10-K 2025-03-20
Q3 2024 $70.3M $10.7M +$5.67M +113% Jul 1, 2024 Sep 30, 2024 10-Q 2024-11-12
Q2 2024 $64.6M $10.2M +$5.15M +103% Apr 1, 2024 Jun 30, 2024 10-Q 2024-08-08
Q1 2024 $59.4M $19.3M +$14.4M +293% Jan 1, 2024 Mar 31, 2024 10-Q 2024-05-17
Q4 2023 $45.1M $30.1M +$26.7M +772% Oct 1, 2023 Dec 31, 2023 10-K 2025-03-20
Q3 2023 $18.4M $5.01M +$3.16M +171% Jul 1, 2023 Sep 30, 2023 10-Q 2024-11-12
Q2 2023 $15.2M $5.02M +$3.21M +177% Apr 1, 2023 Jun 30, 2023 10-Q 2024-08-08
Q1 2023 $12M $4.91M +$3.12M +174% Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-17
Q4 2022 $8.91M $3.46M Oct 1, 2022 Dec 31, 2022 10-K 2024-03-21
Q3 2022 $1.85M Jul 1, 2022 Sep 30, 2022 10-K 2024-03-21
Q2 2022 $1.81M Apr 1, 2022 Jun 30, 2022 10-K 2024-03-21
Q1 2022 $1.79M Jan 1, 2022 Mar 31, 2022 10-K 2024-03-21
* An asterisk sign (*) next to the value indicates that the value is likely invalid.